-
Immunglobuline – Was ist gesichert zur
Prophylaxe und Therapie?
K. Werdan
-
Anti-TNF strategies
E. A. Panacek
-
Elimination of endotoxin – Where are we?
A. Meier-Hellmann, K. Reinhart
-
Adjunctive sepsis therapies: Glucocorticoids -
What is proven?
J. Briegel, E. Kilger, M. Thiel
-
Granulocyte colony-stimulating factor during
sepsis: an update
W. Karzai
-
Prone positioning as a treatment of ARDS patients
L. Gattinoni, P. Taccone, P. Caironi, L. Brazzi
-
Aktuelle Beatmungstrategien – Was ist gesichert?
R. Kopp, R. Rossaint
-
Weaningstrategien – Was ist gesichert?
H. Gerlach
-
Microbial Translocation: Myth or reality?
J. C. Marshall
-
Therapeutische Strategien beim gastrointestinalen
Versagen
M. K. Herbert
-
Standards der Kreislauftherapie bei Sepsis und
Multiorgandysfunktion
A. Meier-Hellmann
-
Rationelle Antibiotikatherapie auf der
Intensivstation
H. Lode, M. Raffenberg, R. Erbes
-
Prophylaxis, diagnosis & therapy of fungal
infections
J. Cohen
-
Monitoring- Globale Hämodynamik
S. G. Sakka
-
The microcirculation and the "pO2
gap" in sepsis and shock
C. Ince
-
Gastrale Tonometrie - Nutzen in der Klinik?
S. Klinzing
-
Strategies to reduce blood transfusion in the ICU
and during the peri-operative period
A. Shander
-
Standards und Perspektiven des mikrobiologischen
Monitorings septischer Erkrankungen
E. Straube
-
Procalcitonin as a marker of the systemic
inflammatory response to infections
K. Reinhart
-
The role of C-reactive protein
J.-L. Vincent
-
The role of recombinant platelet-activating factor
acetylhydrolase in the treatment of sepsis
S. M. Opal
-
Tissue factor pathway inhibitor and severe sepsis
K. Reinhart
-
Antithrombin-III in the treatment of severe
sepsis: The results of a phase III multicenter clinical trial
S. M. Opal